The UofL Infectious Diseases Biorepository was developed in 2005 by expert faculty from the University of Louisville Division of Infectious Diseases for the discovery of new pathogens and biomarkers. Managed through a secure clinical database, the Biorepository stores more than 70,000 human specimen linked to complete clinical data including urine, blood, sputum, oral, nasopharyngeal swabs and isolates. Experts in the Biorepository also provide consultation and quick turnaround for the routine shipping of biological specimens to national and international health system leaders for research projects.
The Infectious Diseases Biorepository has expanded to include high quality human specimens and data support for investigator research in the development of novel diagnostic and therapeutics for COVID-19. The COVID-19 Biobank offers prospective and retrospective specimen selection from the bank of whole blood, serum, plasma, urine, sputum, bronchioalveolar, and tissue samples from subjects hospitalized and test-positive for COVID-19. All COVID-19 Biobank samples are connected to clinical data. The table below lists what is currently possible through our COVID-19 Biobank.